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Abstract
The glycoprotein 130 (gp130) dependent family of cytokines comprises interleukin-6 (IL-6), IL-11, leukemia inhibitory factor
(LIF), cardiotrophin-like cytokine (CLC), ciliary neurotrophic factor (CNTF), cardiotrophin-1 (CT-1) and oncostatin M (OSM).
These cytokines share the membrane gp130 as a common signal transducer. Recently, it was demonstrated that IL-6
promotes, whereas LIF inhibits fetal lung branching. Thus, in this study, the effects on fetal lung morphogenesis of the other
classical members of the gp130-type cytokines (IL-11, CLC, CNTF, CT-1 and OSM) were investigated. We also provide the first
description of these cytokines and their common gp130 receptor protein expression patterns during rat lung development.
Fetal rat lung explants were cultured in vitro with increasing concentrations of IL-11, CLC, CNTF, CT-1 and OSM. Treated lung
explants were morphometrically analyzed and assessed for MAPK, PI3K/AKT and STAT3 signaling modifications. IL-11, which
similarly to IL-6 acts through a gp130 homodimer receptor, significantly stimulated lung growth via p38 phosphorylation.
On the other hand, CLC, CNTF, CT-1 and OSM, whose receptors are gp130 heterodimers, inhibited lung growth acting in
different signal-transducing pathways. Thus, the present study demonstrated that although cytokines of the gp130 family
share a common signal transducer, there are specific biological activities for each cytokine on lung development. Indeed,
cytokine signaling through gp130 homodimers stimulate, whereas cytokine signaling through gp130 heterodimers inhibit
lung branching.
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Introduction
Normal lung development is particularly dependent on tightly
regulated signaling networks, triggered by both its classically
known effectors, such as growth factors, extracellular matrix
molecules and hormones, and by its recently implicated regulatory
factors like inflammatory cytokines [1–4].
The glycoprotein 130 (gp130) dependent family of cytokines or
interleukin 6 (IL-6) family of cytokines is quite a large group of
structurally related cytokines that includes IL-6, IL-11, leukemia
inhibitory factor (LIF), ciliary neurotrophic factor (CNTF),
cardiotrophin-1 (CT-1), cardiotrophin-like cytokine (CLC), and
oncostatin M (OSM) [5,6]. Other family members have recently
emerged (IL-27 and neuropoietin), thus it is likely that the
currently defined gp130 cytokine family is not complete [5,7,8].
These small proteins are grouped in same family, since all signal
through a common signal transducing receptor chain, the gp130.
However, each cytokine interacts with a specific receptor that is a
complex of receptor subunits. Thus, the multimeric receptor
complex for gp130 family of cytokines consists of (i) gp130
homodimers with a ligand-specific a chain for IL-6 and IL-11; (ii)
gp130 heterodimers (gp130/LIFR and gp130/OSMR) without
specific a chain for LIF and OSM; or (iii) gp130 heterodimers with
a ligand-specific a chain (CNTFRa) for CNTF and CLC or a
chain-like for CT-1 [5–7]. Until the moment, the a chain recruited
by CT-1 has not been characterized [5].
The gp130 cytokine receptors signal directly through the Janus
kinase-signal transducer and activator of transcription (JAK-
STAT) pathway, particularly STAT3 and STAT1 [6,9]. Alterna-
tively, gp130 cytokine family can also initiate cell signaling via
other signaling pathways, including the mitogen-activated protein
kinase (MAPK) and phosphatidylinositol-3 kinase (PI3K/AKT)
cascades [6,10,11]. Through these pathways, gp130 cytokine
signaling activates target genes involved in several cellular
responses namely, cell differentiation, survival, apoptosis and
proliferation. Concomitant with these responses, negative regula-
tion of cytokine function is critical to prevent the deleterious
biological consequences of excessive stimulation, and the suppres-
sor of cytokine signaling proteins (SOCS) are well-recognized for
contributing significantly to this process [6,12–14]. In particular,
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inhibitors such as SOCS3 regulate cytokine-induced STAT3
activation by a classical negative feedback loop.
Adding to their reputation as classical regulators of immune
response and inflammation, these cytokines are also well known
for their regulatory role in diverse biological processes including,
hematopoiesis, mammalian fertility, liver and neuronal regenera-
tion, myocardial development, pituitary proliferation, bone
homeostasis, adipocyte differentiation and function, and embry-
onic development [5,6,10,11,15]. Concerning lung development,
IL-6 was demonstrated to have an enhancing effect on lung
explant growth and proved to be an important regulator of normal
lung growth, whereas in opposition to IL-6, LIF was found to
inhibit lung branching [3,4,16]. Such evidences lead us to
speculate that other members of gp130 family of cytokines might
be involved in normal lung development. Moreover, these
cytokines present some functional redundancy, even though they
also exhibit specific biological activities [6,11]. Therefore, we
proposed to investigate the role of other gp130 family of cytokines
on fetal lung growth.
Materials and Methods
This study was carried out in strict accordance with the
recommendations in the ‘Guide for the Care and Use of
Laboratory Animals’, published by the US National Institutes of
Health (NIH Publication No. 85–23, revised 1996). Animal
experiments were also performed according to the Portuguese
law for animal welfare and the protocol was approved by the
Committee on the Ethics of Animal Experiments of the Life and
Health Sciences Research Institute of the University of Minho
(DGV 022162 - 520/000/000/2006). Moreover, all efforts were
made to minimize animal suffering.
Animal model and experimental design
Sprague-Dawley female rats (225 g; Charles-River, Spain) were
maintained in appropriate cages under temperature-controlled
room (22–23uC) on 12 hours light: 12 hours dark cycle, and fed
with commercial solid food. The rats were mated and checked
daily for vaginal plug. The day of plugging was defined as
gestational day 0.5 for time dating purposes. Fetuses were removed
by caesarean section at 13.5 dpc (days post-conception), sacrificed
by decapitation and their lungs dissected for fetal lung explant
cultures.
Immunohistochemistry
Immunostaining was performed on paraformaldehyde-fixed
and paraffin-embedded excised lungs and embryos of different
gestational ages (13.5–21.5dpc). Five mm sections were placed onto
glass microscope slides. Primary antibodies for IL-11 [1:200; IL-11
(H-169), Santa Cruz Biotechnology Inc., USA], CLC [1:50; NNT-
1/BSF-3 (FL-225), Santa Cruz Biotechnology Inc.], CNTF
[1:200; CNTF (R-20), Santa Cruz Biotechnology Inc.], CT-1
[4 mg/mL; CT-1 (3G6D9), Abcam Inc., UK], OSM [1:25; OSM
(A-9), Santa Cruz Biotechnology Inc.] and gp130 receptor [1:100;
GP130 (H-255), Santa Cruz Biotechnology Inc.] were used. Tissue
sections were deparaffinized in xylene and rehydrated in ethanol,
boiled in 10 mM citrate buffer for antigen retrieval and cooled
down at room temperature. Incubation with the primary antibody
occurred at 4uC overnight. Negative control reactions included
omission of the primary antibody and the simultaneous omission
of the primary and secondary antibodies, in both cases immuno-
reactive cytokine staining was not observed. Sections were
incubated with a labeled streptavidin-biotin immunoenzimatic
antigen detection system (UltraVision Large Volume Detection
System Anti-Polyvalent, Horseradish Peroxidase, Lab Vision
Corporation, USA) according to manufacturer’s instructions. For
visualization of the immune reaction, a diaminobenzidine
tetrahydrochloride solution (Dako, Denmark) was used. Sections
were finally counterstained with hematoxylin. The slides were
observed and photographed with Olympus BX61 microscope
(Olympus, Japan). At least three independent experiments were
performed, in each a different set of slides comprising the whole
range of gestational ages plus adult, obtained from different
individual samples, was used.
Fetal lung explant cultures
Harvesting and dissection of 13.5 dpc lungs was made in DPBS
(Lonza, Switzerland) under a dissection microscope (Leica
MZFLIII, Switzerland). The lungs were transferred to Nucleopore
membranes with an 8 mm pore size (Whatman, USA), previously
presoaked in DMEM (Invitrogen, UK) for 1 hour, and incubated
in a 24-well culture plates (Nunc, Denmark). Floating cultures of
the explants were incubated in 200 mL of 50% DMEM, 50%
nutrient mixture F-12 (Gibco, USA) supplemented with 100 mg/
mL streptomycin, 100 units/mL penicillin (Gibco), 0.25 mg/mL
ascorbic acid (Sigma-Aldrich, USA) and 10% FCS (Gibco). The
fetal lung explants were incubated in a 5% CO2 incubator at 37uC
for 96 hours, and the medium was replaced every 48 hours. The
branching morphogenesis was monitored daily by photographing
the explants. At day 0 (D0: 0 hours) and day 4 (D4: 96 hours) of
culture, the total number of peripheral airway buds (branching) in
all lung explants was determined, by counting the number of
peripheral airway epithelial buds of the developing respiratory
tree. Three additional morphometric parameters were assessed
using AxionVision Rel. 4.3 (Carl Zeiss, Germany) imaging
software: (1) epithelial perimeter which relates to the contour of
the internal airways of the explant and is defined by the folded
epithelial surface, (2) explant area and (3) external perimeter both
defined by the outer edge of the whole fetal lung explant. These
results were expressed as D4/D0 ratio.
IL-11, CLC, CNTF, CT-1 and OSM supplementation studies
In vitro cultures were daily supplemented with several doses of
recombinant IL-11 (0.1; 1; 10; 100 pg/mL), CLC (0.003; 0.03;
0.3; 3; 30 nM), CNTF (0.1; 1; 10; 100; 1000 ng/mL), CT-1 (0.1;
1; 10; 100; 200 ng/mL), and OSM (0.1; 1; 10; 100 ng/mL). All
recombinant proteins were purchased from R&D Systems (USA).
Per each tested dose at least nine, often more, fetal lung explants
were used; likewise twelve lung explants were used as control. For
CLC and CT-1 supplementation studies the control explants were
supplemented with 4 mM of sterile HCl (according to manufac-
turer’s instructions of recombinant proteins reconstitution). Sam-
pled lung explants were obtained in three independent experi-
ments performed.
After 4 days in culture, control and cytokine treated lung
explants at selected concentrations (IL-11 at 0.1 pg/mL; CLC at
30 nM; CNTF at 1000 ng/mL; CT-1 at 200 ng/mL; OSM at
100 ng/mL) were processed for western blot analysis according to
the method described below.
Western blot analysis
Pooled samples of the cultured lung explants were processed for
western blot analysis. Proteins were obtained according to Kling et
al [17]. Ten mg of protein were loaded onto 10% acrylamide
minigels, electrophoresed at 100 V at room temperature and then
transferred to nitrocellulose membranes (HybondTM -C Extra,
GE Healthcare Life Sciences, UK). Blots were probed with
antibodies to non-phosphorylated and phosphorylated forms of
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p38, p44/42 (ERK1/2), JNK, AKT and STAT3 (1:1000; Cell
Signaling Technology Inc.), additionally SOCS3 (1 mg/mL;
Abcam Inc.), PCNA [Proliferating cell nuclear antigen] (1:500;
Santa Cruz Biotechnology Inc.) and PARP [Poly (ADP-ribose)
polymerase] (1:1000; BD Biosciences, USA) antibodies were also
used according to the manufacturer’s instructions. For loading
control, blots were probed with b-tubulin (1:150000, Abcam).
Afterwards blots were incubated with a secondary horseradish
peroxidase conjugate (Santa Cruz Biotechnology Inc.), developed
with Super Signal West Femto Substrate (Pierce Biotechnology,
USA) and the chemiluminescent signal was captured using the
Chemidoc XRS (Bio-Rad, USA). Quantitative analysis was
performed with Quantity One 4.6.5 1-D Analysis Software (Bio-
Rad). Three independent experiments were performed (n = 3).
Statistical analysis
All quantitative data are presented as mean 6 SEM. Statistical
analysis was performed using the statistical software SigmaStat
(version 3.5; Systat Software Inc., USA). For supplementation
studies one-way ANOVA was used and for intracellular signaling
pathways analysis t-test was used. The Student-Newman-Keuls test
was used for post-test analysis. Statistical significance was set at
p,0.05.
Results
Gp130 cytokines expression pattern during rat fetal lung
development
Spatio-temporal protein expression pattern of IL-11, CLC,
CNTF, CT-1, OSM and gp130 receptor were assessed in the
developing lung at five gestational ages, specifically 13.5, 15.5,
17.5, 19.5 and 21.5 dpc and also in the adult lung tissue.
Immunohistochemistry revealed that all these cytokines and their
common gp130 receptor are expressed throughout all studied
gestational ages in the fetal lung (Figures 1, 2, 3, 4, 5, 6). IL-11 is
first mainly expressed in the undifferentiated mesenchyme at 13.5
Figure 1. IL-11 expression pattern during fetal lung development. IL-11 is expressed throughout all stages of lung development studied,
from early 13.5 dpc until late 21.5 dpc and also in the adult. Representative immunohistochemistry staining of (A–E) developing lung and (F) adult
lung. Original magnification 6100.
doi:10.1371/journal.pone.0067607.g001
Figure 2. CLC expression pattern during fetal lung development. CLC is expressed throughout all stages of lung development studied, from
early 13.5 dpc until late 21.5 dpc and also in the adult. Representative immunohistochemistry staining of (A–E) developing lung and (F) adult lung.
Original magnification 6100.
doi:10.1371/journal.pone.0067607.g002
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and 15.5 dpc, however at late pseudoglandular stage, 17.5 dpc,
immunostaining is observed in both mesenchyme and in the
epithelial lining of proximal and distal airways. At late gestational
stages, IL-11 is predominantly associated with both bronchial and
alveolar epithelium, similarly to the adult tissue (Figure 1). CLC
immunostaining is detected in the embryonic mesenchyme at
13.5 dpc, and remains predominant in this tissue at subsequent
gestational stages; inversely as gestation progresses CLC epithelial
expression is mostly observed, as illustrated at term as well as in
the adult (Figure 2). CNTF expression is also detected as early as
13.5 dpc in the primitive mesenchymal tissue, from 17.5 dpc until
term as airways develop CNTF epithelial expression gradually
becomes predominant. In the adult, CNTF staining is restricted to
the bronchi and alveoli (Figure 3). Mesenchymal CT-1 expression
is present early in gestation, 13.5 dpc, and is concomitant to
epithelial expression since 15.5 dpc onwards, throughout gestation
CT-1 immunostaining in the airways is increasingly more
apparent and also restricted to bronchi and alveoli epithelial
lining in the adult (Figure 4). Similarly, OSM is also detectable
since 13.5 dpc in the mesenchyme. At 15.5 dpc its expression is
evident in both mesenchymal and epithelial embryonic tissues.
OSM positive immunoreactivity in the epithelium of airways is
clearly detected since 17.5 dpc and remains until term. Likewise,
in the adult tissue protein expression is observed only in both
bronchial and alveolar airways (Figure 5). Gp130 receptor protein
is detected in the embryonic pulmonary mesenchyme at 13.5 dpc.
Also early in development, at 15.5 dpc, epithelial expression of
gp130 is already observed, and at subsequent gestational ages its
expression remains predominantly associated with the developing
epithelium. Additionally, gp130 immunostaining in the adult is
also evident in the proximal and distal epithelial tissue (Figure 6).
Role of gp130 cytokines on rat fetal lung development
This study aimed to clarify the role of gp130 dependent family
of cytokines on lung morphogenesis. Thus, rat fetal lung explants
cultured in vitro were treated daily with increasing concentrations
Figure 3. CNTF expression pattern during fetal lung development. CNTF is expressed throughout all stages of lung development studied,
from early 13.5 dpc until late 21.5 dpc and also in the adult. Representative immunohistochemistry staining of (A–E) developing lung and (F) adult
lung. Original magnification 6100.
doi:10.1371/journal.pone.0067607.g003
Figure 4. CT-1 expression pattern during fetal lung development. CT-1 is expressed throughout all stages of lung development studied,
from early 13.5 dpc until late 21.5 dpc and also in the adult. Representative immunohistochemistry staining of (A–E) developing lung and (F) adult
lung. Original magnification 6100.
doi:10.1371/journal.pone.0067607.g004
gp130 Family of Cytokines and Fetal Lung Growth
PLOS ONE | www.plosone.org 4 June 2013 | Volume 8 | Issue 6 | e67607
of recombinant IL-11, CLC, CNTF, CT-1 and OSM. In
Figure 7A, representative examples of fetal lung explants treated
with increasing IL-11 concentrations, after 4 days in culture, are
illustrated. IL-11 appears to have an enhancing effect on lung
explant growth which is maximal at the lowest concentration
tested, 0.1 pg/mL. In fact, an increase in the total number of
peripheral airway buds (Figure 7B), epithelial perimeter
(Figure 7C), area (Figure 7D) and external perimeter (Figure 7E)
of lung explants was observed in all concentrations tested, except
the highest, 100 pg/mL. In all the above mentioned morphomet-
ric parameters, explants treated with the highest dose presented
the most similar effect to the control explants. In detail, increasing
doses of IL-11 induced a biphasic effect in all the morphometric
parameters assessed, generally the lowest dose of IL-11 enhanced
explant growth, whereas increasingly high doses gradually reduced
explant growth when compared to the maximal effect observed.
Regarding the role of CLC in fetal lung growth, in Figure 8A
representative examples of lung explants treated with increasing
CLC concentrations, after 4 days in culture, are illustrated. CLC
appears to have a dose-effect inhibitory action on lung explant
growth. In fact, a decrease in the total number of peripheral
airway buds (Figure 8B), epithelial perimeter (Figure 8C), area
(Figure 8D) and external perimeter (Figure 8E) of lung explants
was observed in all concentrations tested, and this effect is most
significant in the highest CLC concentration studied, 30 nM.
In Figure 9A, representative examples of fetal lung explants
treated with increasing CNTF concentrations, after 4 days in
culture, are illustrated. CNTF appears to have an inhibitory action
on lung explants growth, with the maximal effect induced by the
highest CNTF concentration studied, 1000 ng/mL.
Concerning CT-1, CT-1 appears to have a dose-effect
inhibitory action on lung explants growth, as illustrated in
figure 10A. In fact, a decrease in the total number of peripheral
airway buds (Figure 10B), epithelial perimeter (Figure 10C), area
(Figure 10D) and external perimeter (Figure 10E) of lung explants
Figure 5. OSM expression pattern during fetal lung development. OSM is expressed throughout all stages of lung development studied,
from early 13.5 dpc until late 21.5 dpc and also in the adult. Representative immunohistochemistry staining of (A–E) developing lung and (F) adult
lung. Original magnification 6100.
doi:10.1371/journal.pone.0067607.g005
Figure 6. Gp130 receptor expression pattern during fetal lung development. Gp130 receptor is expressed throughout all stages of lung
development studied, from early 13.5 dpc until late 21.5 dpc and also in the adult. Representative immunohistochemistry staining of (A–E)
developing lung and (F) adult lung. Original magnification 6100.
doi:10.1371/journal.pone.0067607.g006
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was observed in all concentrations tested, this effect is most
significant in the highest CT-1 concentration studied, 200 ng/mL.
As illustrated in figure 11A, OSM appears to have an inhibitory
effect on lung branching. In fact, OSM at 100 ng/mL induces a
significant decrease in the total number of peripheral airway buds
(Figure 11B), epithelial perimeter (Figure 11C), area (Figure 11D)
and external perimeter (Figure 11E) of lung explants.
Gp130 cytokines supplementation effects on intracellular
signaling pathways
The receptors of gp130 cytokines directly control the activities
of STAT, MAPK, and PI3K/AKT signaling pathways, and
simultaneously activate SOCS negative feedback regulation. In
order to further investigate gp130 cytokines effects on fetal rat lung
growth, treated lung explants were evaluated for signaling
modulation of these pathways. Pooled samples of lung explants
individually treated with recombinant cytokines (selected due to its
maximal effect either on stimulation or inhibition of explants
growth) were used to assess protein expression levels of non-
phosphorylated and phosphorylated forms of p38, p44/42
(ERK1/2), JNK, AKT and STAT3 by western blot, likewise
SOCS3 protein expression levels were also assessed (Figure 12).
Resulting signaling pathway alterations induced by gp130 cytokine
stimulation are summarized in Table 1. On one hand, lung growth
stimulation induced by IL-11 significantly increased p38 phos-
phorylation. On the other hand, inhibition of lung growth induced
by CLC, significantly reduced JNK and AKT phosphorylation
levels. Both CNTF and CT-1-induced inhibition of lung growth
significantly stimulated STAT3 phosphorylation and decreased
JNK phosphorylation. Additionally, CNTF treatment also induced
a significant increase of AKT phosphorylation, whereas CT-1
treatment significantly increased p38 phosphorylation. OSM
inhibitory effects on lung growth appear to be mediated by
significantly increase of p38 and p44/42 phosphorylation, and also
of AKT and STAT3 phosphorylation. Gp130 cytokines supple-
mentation, comparatively to no supplementation, induced an
Figure 7. IL-11 supplementation studies in a fetal lung explant culture system. (A) Representative examples of fetal lung explants treated
daily with increasing concentrations of recombinant IL-11, after 4 days in culture. Original magnification:625. (B) Number of peripheral airway buds ;
(C) Epithelial perimeter; (D) Area; (E) External perimeter of lung explants treated with IL-11. Results are expressed as ratio of day 4 (D4) and day 0 (D0)
of culture (D4/D0 ratio), and also as absolute number in D0 (black bar) and D4 (white bar). p,0.05:
* vs. IL-11 at 0 pg/mL (control), 1 vs. IL-11 at 0.1 pg/
mL, ¥ vs. IL-11 at 1 pg/mL.
doi:10.1371/journal.pone.0067607.g007
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increase in SOCS3 expression levels, except for CLC treatment.
Both IL-11 and CNTF stimulation significantly increased SOCS3
expression.
Gp130 cytokines supplementation effects on
proliferation and apoptosis
Gp130 cytokines stimulatory or inhibitory effects on fetal rat
lung explant growth were further explored by assessing the protein
expression levels of proliferation and apoptosis markers, PCNA
and cleaved PARP respectively (Figure 13). Western blot was
performed, using pooled samples of lung explants individually
treated with recombinant cytokines. Concerning proliferation, IL-
11 stimulatory effects on lung growth are concomitant with a
significant increase of PCNA levels. Additionally, lung growth
inhibitory cytokines, CLC, CNTF, CT-1 and OSM did not induce
changes in PCNA levels relatively to no supplementation control
(Figure 13B). In relation to apoptosis, inhibition of lung growth by
CLC, CNTF, CT-1 and OSM induced a decrease in cleaved
PARP, comparatively to growth stimulating-IL-11. Concurrently,
IL-11 supplementation induced the highest expression level of
cleaved PARP observed, and OSM the lowest, both significantly
different relatively to control (Figure 13C).
Discussion
The gp130 cytokine family collectively exhibits a broad range of
physiological functions, including important roles in embryonic
development. Recently, some of these cytokines, namely IL-6 and
LIF, have been proposed to be mediators in fetal lung
development [3–4], but otherwise little is known about the role
of additional classical members of this family in the developing
lung.
Moreover, information regarding protein expression patterns of
these cytokines and their common gp130 receptor during
embryonic rat pulmonary development is lacking from literature.
Therefore, the present study demonstrated, for the first time, that
gp130 receptor and its ligand cytokines are expressed during lung
Figure 8. CLC supplementation studies in a fetal lung explant culture system. (A) Representative examples of fetal lung explants treated
daily with increasing concentrations of recombinant CLC, after 4 days in culture. Original magnification: 625. (B) Number of peripheral airway buds;
(C) Epithelial perimeter; (D) Area; (E) External perimeter of lung explants treated with CLC. Results are expressed as ratio of day 4 (D4) and day 0 (D0) of
culture (D4/D0 ratio), and also as absolute number in D0 (black bar) and D4 (white bar). p,0.05:
* vs. CLC at 0 nM (control plus 4 mM HCl), 1 vs. CLC at
0.003 nM, ¥ vs. CLC at 0.03 nM, { vs. CLC at 0.3 nM, ` vs. CLC at 3 nM.
doi:10.1371/journal.pone.0067607.g008
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development. IL-11, CLC, CNTF, CT-1 and OSM are expressed
at very early gestational stages of lung development, suggesting a
biological role for these cytokines in early normal development of
this branching organ. These cytokines share a similar protein
expression pattern, in early stages of development with prevalence
in undifferentiated tissues, all gp130 cytokines are expressed
predominantly in the embryonic mesenchyme. Interestingly, as
gestation progresses and airways develop and differentiate, gp130
cytokine expression becomes increasingly more restricted to both
bronchial and alveolar epithelium. Concurring with our findings,
several expression studies regarding gp130 cytokines, although
referring mostly to IL-11, CLC, CNTF, CT-1 and OSM mRNA
levels, have proved the expression of these cytokines in the murine
adult lung [5,18–24]. Furthermore our findings demonstrated that
these cytokines also share a similar protein expression pattern in
the rat fetal lung and, that for the most part of pulmonary
development, gp130 cytokines expression is highly associated with
both proximal and distal airways. This is found to be in agreement
with further evidences that showed OSM [23] and CLC [25]
expression in the pulmonary airway epithelium. It is also
demonstrated that gp130 receptor protein is present in embryonic
mesenchyme since early pulmonary development, and as gestation
progresses its expression is predominantly associated with the
developing epithelium, similarly to both the expression patterns
observed for gp130 cytokines and LIFR in lung development [4].
In order to further clarify the role of the gp130 family of
cytokines in lung branching morphogenesis, in vitro supplementa-
tion studies were performed individually. Thus, fetal lung explants
were cultured with increasing concentrations of IL-11, CLC,
CNTF, CT-1 or OSM, selected according to literature [26–35].
Supplementation studies showed that cytokines within the gp130
family can elicit opposite effects in lung explant growth. Such
observation suggests that despite their shared use of the common
receptor subunit gp130, these cytokines can generate contradictory
signals in branching morphogenesis. Furthermore, intracellular
signaling contribution to the effects of each cytokine on fetal lung
Figure 9. CNTF supplementation studies in a fetal lung explant culture system. (A) Representative examples of fetal lung explants treated
daily with increasing concentrations of recombinant CNTF, after 4 days in culture. Original magnification:625. (B) Number of peripheral airway buds;
(C) Epithelial perimeter; (D) Area; (E) External perimeter of lung explants treated with CNTF. Results are expressed as ratio of day 4 (D4) and day 0 (D0)
of culture (D4/D0 ratio), and also as absolute number in D0 (black bar) and D4 (white bar). p,0.05:
* vs. CNTF at 0 nM (control), 1 vs. CNTF at 0.1 ng/mL,
¥ vs. CNTF at 1 ng/mL, { vs. CNTF at 10 ng/mL.
doi:10.1371/journal.pone.0067607.g009
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growth were investigated by assessing non-phosphorylated and
phosphorylated protein expression levels of several intracellular
mediators, namely p38, p44/42, JNK, AKT, STAT3, and total
SOCS3. It is well-established that numerous players account for
the molecular basis of cytokine action, thus unsurprisingly in fetal
lung development each cytokine proved to elicit the activation of
either simple or combinatory signals from different signal-
transducing pathways. Additionally, gp130 cytokines effects on
lung explant growth were further explored by assessing prolifer-
ation and apoptosis levels.
In this study, it was demonstrated that IL-11 supplementation
stimulates lung branching evidenced by increased number of
peripheral airways buds, epithelial perimeter, area and external
perimeter of fetal lung explants, whereas CLC, CNTF, CT-1 and
OSM inhibit lung growth. Together with previously obtained
results which demonstrated that IL-6 and LIF have opposite effects
in branching morphogenesis, while the first stimulated lung
explant growth the latter inhibited, the current study extensively
contributes for a thorough comprehension of the role of these
cytokines in the complex process of lung development.
Similarly to what was previously described for IL-6, IL-11
supplementation stimulated fetal lung branching. This stimulatory
effect is concomitant with a significant increase in proliferation.
IL11 supplementation also significantly, elicited the highest level of
apoptosis observed. It is reasonable to expect an increase in
proliferation in a branching stimulatory context mainly supported
by epithelial development [1]. It is also known that apoptosis can
be detected throughout the lung developmental stages, however it
is most prominent during the pseudoglandular stage when
branching morphogenesis occurs [36,37,38]. In addition, most
cells undergoing apoptosis are reported to be located in the
mesenchyme [36,38,39]. Therefore the combination of these
processes is likely responsible for the observed IL-11 growth
stimulation. Interestingly, IL-11 has been demonstrated to
stimulate proliferation and differentiation of intestinal cells and
to prevent apoptosis of epithelial cells [40,41]. Regarding the lung,
Figure 10. CT-1 supplementation studies in a fetal lung explant culture system. (A) Representative examples of fetal lung explants treated
daily with increasing concentrations of recombinant CT-1, after 4 days in culture. Original magnification: 625. (B) Number of peripheral airway buds;
(C) Epithelial perimeter; (D) Area; (E) External perimeter of lung explants treated with CT-1. Results are expressed as ratio of day 4 (D4) and day 0 (D0)
of culture (D4/D0 ratio), and also as absolute number in D0 (black bar) and D4 (white bar). p,0.05:
* vs. CT-1 at 0 ng/mL (control plus 4 mM HCl), 1 vs.
CT-1 at 0.1 ng/mL, ¥ vs. CT-1 at 1 ng/mL, { vs. CT-1 at 10 ng/mL, ` vs. CT-1 at 100 ng/mL.
doi:10.1371/journal.pone.0067607.g010
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IL-11 is produced by a variety of structural cells (fibroblasts,
epithelial cells, human airway smooth muscle cells] and eosino-
phils in response to a variety of stimuli [42,43]. Indeed, IL-11 acts
as a healing cytokine in the asthmatic airway and also provides
protective effects against oxidant-mediated injury in fetal and adult
lung [44,45].
On the contrary, it was demonstrated that CLC, CNTF, CT-1
and OSM inhibit lung growth. Simultaneously, these inhibitory
cytokines showed decreased apoptosis levels comparatively to
stimulatory IL-11, moreover OSM presented a significant
decrease in apoptosis relative to control. In agreement, others
have previously reported diminished fetal lung branching in the
presence of apoptosis inhibition [36,46]. Several evidences point
towards a role of these inflammatory cytokines in varied aspects of
lung physiology. During development, CLC is expressed in lung,
particularly in distal airway epithelium, as well as several other
organs [47], suggesting important biological roles of this cytokine.
In opposition to lung growth inhibition here demonstrated, during
kidney development (also a branching organ), CLC promotes
mesenchymal to epithelial conversion and nephrogenesis [28].
CNTF is described to be widely expressed in the adult [20], but
during embryonic development, CNTF is specifically expressed in
rat pineal gland and eyes [48]. This cytokine has been described to
act as a lesion factor, preventing neuronal cell death and
facilitating axonal regeneration after nerve injury [32]. CT-1 is
expressed in both adult and fetal lung and also in numerous other
embryonic and adult tissues [5,21,22,49]. In opposition to the
inhibitory effect on fetal lung growth described in this study, CT-1
has been related with hypertrophic and cytoprotective actions
[49]. In fact, CT-1 has been related with chronic asthma,
contributing to airway wall thickening and hypertrophy of airway
smooth muscle [22]. Lastly, OSM is expressed in hematopoietic
tissues, choroid plexus and limb during fetal life [50]. After birth, it
is detectable in many other organs, and also the lung, specifically
in alveolar and bronchiolar epithelium [23,24]. Moreover, OSM is
Figure 11. OSM supplementation studies in a fetal lung explant culture system. (A) Representative examples of fetal lung explants treated
daily with increasing concentrations of recombinant OSM, after 4 days in culture. Original magnification: 625. (B) Number of peripheral airway buds;
(C) Epithelial perimeter; (D) Area; (E) External perimeter of lung explants treated with OSM. Results are expressed as ratio of day 4 (D4) and day 0 (D0)
of culture (D4/D0 ratio), and also as absolute number in D0 (black bar) and D4 (white bar). p,0.05:
* vs. OSM at 0 ng/mL (control), { vs. OSM at 0.1 ng/
mL, 1 vs. OSM at 1 ng/mL, ¥ vs. OSM at 10 ng/mL.
doi:10.1371/journal.pone.0067607.g011
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a potent mediator of lung inflammation and extracellular matrix
accumulation [51].
Our findings on this dual contribution of gp130 family of
cytokines, with inductive and suppressive actions in lung growth,
clearly suggest a regulatory role in fetal lung development.
Previously stressing a role for gp130 signaling during embryo
development are many studies of transgenic and knockout mice for
different components of this cytokine family or their receptors,
which report defects in bone and neurologic development,
disrupted placental architecture, hypoplastic development and a
decrease in fetal liver hematopoiesis. The most severe phenotypes
are displayed by mice lacking receptor components used by several
members of the gp130 family. For example, gp130 or LIFR
knockout mice die during development or shortly after birth
[11,52,53]. Likewise, conditional gp130-mutant mice presented
pulmonary defects and developed emphysema with increasing age
[54]. In the present study, it was revealed that individual gp130-
type cytokines can both enhance or inhibit fetal lung growth.
Besides, providing specificity for individual cytokines in fetal lung
development, these data underlines that cytokines operating
through gp130 homodimers may induce different and even
opposite biological responses than those operating through
gp130 heterodimers. Both IL-6 and IL-11 receptors are gp130
homodimers and stimulate lung growth, whereas all the other
receptors for this family of cytokines are gp130 heterodimers and
inhibit lung growth (Figure 14). Thus, the main findings of this
study stress the composition of these signaling receptor complexes
as an important mechanism to acquire signaling specificity from
pleiotropic-acting cytokines in lung development. This is in
agreement with the well-documented fact that such cytokines
with pleiotropic activities can also retain tissue-specific activities.
In fact, several mechanisms can be accountable for generating and
limiting those responses, specifically: cytokine restricted temporal
and spatial release, differential expression of cell surface receptors
and different signaling pattern between gp130 homodimers and
heterodimers [55].
Cytokine signaling on a developing lung cell-specific context
triggers diverging and non-overlapping intracellular signaling
cascades. For instance, IL-11 stimulating effect on lung growth
was associated with an increase in p38 phosphorylation. Interest-
ingly, the stimulation of lung growth induced by IL-6 was also
previously reported to be associated with increased p38 activation
[4]. In the case of gp130 cytokines that exert an inhibitory effect in
lung explant growth, diverse and combinatory intracellular signals
are more frequent. Clearly this study emphasizes that also in lung
branching morphogenesis, gp130 cytokine receptor activation is a
rather complex means of initiation of signal transduction that leads
to numerous possible signaling patterns able to elicit a similar
biological outcome. CLC induced lung growth inhibition and
concomitantly a decrease in the activation of JNK and AKT. Both
CNTF and CT-1-induced lung growth inhibition is associated
with activation of STAT3 and decreased JNK phosphorylation.
CNTF additionally activates PI3K/AKT cascade whereas CT-1
activates p38. OSM inhibition of lung growth demonstrated to
activate PI3K/AKT, different MAPK signaling pathways (p38
and p44/42) and also STAT3.
Unsurprisingly, gp130 cytokines fetal lung explant supplemen-
tation, comparatively to no supplementation, induced an increase
in SOCS3 expression levels, except for CLC treatment. SOCS3 is
rapidly induced following cytokine stimulation, both in vitro and in
vivo. Additionally it is well-established that STAT1 and STAT3
contribute significantly to upregulate socs3 gene [12–14,56]. In
agreement, we observe a significant increase in STAT3 activation
concomitant with increased SOCS3 expression, comparatively to
no stimulation, in CNTF, CT-1 and OSM treatments. Inversely,
such is not observed regarding IL-11 and CLC stimulation, the
first shows significantly increased SOCS3 expression and no
apparent STAT3 activation, CLC stimulation did not elicit
STAT3 activation neither SOCS3 overexpression. Considering
that SOCS are induced via JAK/STAT pathway, which in its turn
is initiated upstream by gp130 cytokines, and subsequently act
preventing STAT phosphorylation, they ultimately suppress
cytokine signaling in a classical feedback inhibition [13,56].
Narrowing cytokine stimulation to a single dose, instead of a
range when investigating alterations in STAT phosphorylation
and SOCS expression, may be accountable for missing observa-
tion of the whole negative feedback loop response, and rather be
restricted to observe partial cellular responses of this loop. This is
Figure 12. Analysis of intracellular signaling pathways that IL-11, CLC, CNTF, CT-1 and OSM supplementation mediates on lung
growth. (A) Western blot analysis of p38, p44/42, JNK1/2, AKT, STAT3 and SOCS3, and also diphosphorylated forms of p38 (dp-p38), p44/42 (dp-p44/
42), SAPK/JNK (dp-JNK1/2), AKT (dp-AKT) and STAT3 (dp-STAT3) in control (1), control plus 4 mM HCl for CLC and CT-1 lung explants (2) and treated
with IL-11 at 0.1 pg/mL (3), CLC at 30 nM (4), CNTF at 1000 ng/mL (5), CT-1 at 200 ng/mL (6), and OSM at 100 ng/mL (7). Control loading was
performed using b-tubulin (55 kDa). p38 corresponds to 38 kDa. p44/42 corresponds to 44 and 42 kDa, respectively. JNK1 and 2 corresponds to 46
and 54 kDa, respectively. AKT corresponds to 60 kDa. STAT3 corresponds to two bands, 79 and 86 kDa. SOCS3 corresponds to 30 kDa. Semi-
quantitative analysis for (B) dp-p38, (C) dp-p44/42, (D) dp-JNK1/2, (E) dp-AKT, (F) dp-STAT3, and (G) SOCS3. Results are presented as arbitrary units
normalized for b-tubulin and the respective control. p,0.05: * vs. control.
doi:10.1371/journal.pone.0067607.g012
Table 1. Gp130 cytokines effects on intracellular signaling pathways and lung growth.
Cytokine Effect on intracellular signaling Effect on fetal lung
IL11 q p38 phosphorylation; q SOCS3 expression Stimulation of lung growth
CLC Q JNK and AKT phosphorylation Inhibition of lung growth
CNTF Q JNK phosphorylation; qAKT and STAT3 phosphorylation; q SOCS3 expression Inhibition of lung growth
CT-1 Q JNK phosphorylation; q p38 and STAT3 phosphorylation Inhibition of lung growth
OSM q p38, p44/42, AKT and STAT3 phosphorylation Inhibition of lung growth
Analysis of the intracellular signaling pathways that IL-11, CLC, CNTF, CT-1 and OSM supplementation mediates on fetal lung growth. Note: (q) (Q) arrows indicate
increased and decreased, respectively.
doi:10.1371/journal.pone.0067607.t001
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likely to explain our diverse STAT3/SOCS3 signaling findings,
because only a specific dose of a particular gp130 cytokine was
analyzed. Moreover both, lung growth stimulating IL-11 dose and
lung growth inhibiting CNTF dose significantly increased SOCS3
expression, proving that gp130 cytokines regulation mechanisms
are induced independently of distinct physiological outcomes in
fetal lung development.
The role of gp130 cytokine signaling negative regulation in the
multiplicity of networks that are activated in response to these
cytokines is often difficult to elucidate. Therefore we acknowledge,
that future studies resourcing to other strategies such as gene
expression profiling, blocking parts of the signaling cascade or
using knockout technology in the context of fetal lung develop-
ment would provide a more thorough insight on the gp130-
induced signaling pathways and its regulation. Collectively, these
results suggest that integration of the activities of multiple
pathways might ultimately provide a balanced biological outcome
intended to respond to a particular physiological situation.
In conclusion, in a similar way to IL-6, IL-11 acts in a gp130
homodimer receptor and it was demonstrated that stimulates lung
branching. On the other hand, CLC, CNTF, CT-1 and OSM
receptors are gp130 heterodimers and it was described that they
inhibit lung growth. All these results demonstrated that cytokine
signaling through gp130 homodimers stimulate, whereas cytokine
signaling through gp130 heterodimers inhibit lung branching.
This specificity of gp130-type cytokines might represent a
regulatory mechanism of lung morphogenesis, intrinsic to this
family of cytokines, in order to achieve the correct lung growth.
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